Registered Attendees

Registered Attendees

Print This Page

Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online before the meeting...these abstracts will be available in the Abstract Book at the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Close Window
Fairmont Chateau Whistler Floorplan

Fairmont Chateau Whistler Floorplan

Print This Page



Close Window

This meeting took place in 2014



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Inflammation, Infection and Cancer (X1)


Organizer(s) Johanna A. Joyce, Timothy C. Wang and Frances R. Balkwill
March 9—14, 2014
Fairmont Chateau Whistler • Whistler, British Columbia Canada
Discounted Abstract Deadline: Nov 6, 2013
Abstract Deadline: Dec 10, 2013
Scholarship Deadline: Nov 6, 2013
Discounted Registration Deadline: Jan 9, 2014

Sponsored by BioLegend, Inc., Infinity Pharmaceuticals, Inc. and Roche


Summary of Meeting:
For many years, the presence of leukocytes in tumors had been thought to be a consequence of a failed attempt at cancer cell destruction. However, in the past decade it has emerged that tumors are not only effective in escaping from immune-mediated rejection, they also modify certain inflammatory cell types to render them tumor promoting rather than tumor suppressive. Indeed, inflammatory cells are an important component of the tumor microenvironment, and numerous clinical studies have established a positive correlation between inflammation and cancer progression. This conference will cover the latest research on the roles of inflammation and inflammatory cell subtypes on cancer initiation and progression. A special focus will be placed on emerging findings regarding the contributions of the host microbiome and infectious agents in eliciting an initial inflammatory response, and how that predisposes to specific types of cancer. Throughout the meeting there will be an emphasis placed not only on the mechanisms underlying the critical functions of infection and inflammation in cancers, but also on how to therapeutically target these processes in cancer. A critical component of this conference on “Inflammation, Infection and Cancer” will be the joint sessions held with the companion meeting on “Immune Evolution in Cancer”, emphasizing the latest results in understanding and therapeutically targeting the functions of different immune cells in the tumor microenvironment.

View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


SUNDAY, MARCH 9

16:00—20:00
Arrival and Registration


MONDAY, MARCH 10

07:00—08:00
Breakfast

08:00—10:00
Keynote Session (Joint)
Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting

* Johanna A. Joyce, Memorial Sloan-Kettering Cancer Center, USA

* Suzanne Ostrand-Rosenberg, University of Maryland, USA

Robert D. Schreiber, Washington University School of Medicine, USA
Using Genomics to Define Cancer Immunoediting Mechanisms and Inform Cancer Immunotherapy

Alexander Y. Rudensky, HHMI/Memorial Sloan-Kettering Cancer Center, USA
Differentiation and Function of Regulatory T Cells and Cancer

10:00—10:20
Coffee Break

10:20—12:15
Inflammation and Immunity in the Tumor Microenvironment (Joint)
Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting

* Timothy C. Wang, Columbia University

Andrew J. Dannenberg, Weill Medical College of Cornell University, USA
The Obesity-Inflammation Connection: Implications for Breast Cancer

Lisa M. Coussens, Oregon Health & Science University, USA
Impact of Innate and Adaptive Immunity on Cancer-Associated Chronic Inflammation

Allison S. Harney, Albert Einstein College of Medicine, USA
Short Talk: Perivascular Macrophages Induce Localized, Transient Blood Vessel Permeability and Tumor Cell Intravasation

Florian R. Greten, Institute for Tumor Biology and Experimental Therapy, Germany
Short Talk: Stat3 Controlled Lysosomal Membrane Permeabilization in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumor Initiation

Jeffrey W. Pollard, Queen's Medical Research Institute, UK
Macrophage Promotion of Tumor Progression and Metastasis

12:15—13:00
Poster Setup

13:00—22:00
Poster Viewing

12:15—14:30
On Own for Lunch and Recreation

14:30—16:30
Workshop 1: High-Throughput Approaches to Analyze and Target Immune Cell Functions in Cancer (Joint)

* Ming O. Li, Memorial Sloan-Kettering Cancer Center, USA

Matthew H. Spitzer, Stanford University, USA
Revealing the Tumor-Immune Network via Single-Cell Mass Cytometry

Zlatko Trajanoski, Innsbruck Medical University, Austria
Intratumoral Immune Landscape, Tumor Immunogenicity and Antigenome in Human Colorectal Cancer

Lisa Sevenich, Memorial Sloan Kettering Cancer Center, USA
A Brain Metastasis-Promoting Role for Cathepsin S Identified from Analysis of Tumor- and Stroma-Supplied Proteolytic Networks

Neta Erez, Tel Aviv University, Israel
Pro-Inflammatory Signaling by Cancer-Associated Fibroblasts Co-Evolves during Mammary Carcinogenesis

Kaisa Thorell, Gothenburg University, Sweden
Differential Expression of Kynurenine Pathway Enzymes in Early Stomach Cancer Development

Matthew M. Gubin, Washington University in St. Louis, USA
Using Genomics to Identify Antigenic Targets of Checkpoint Blockade Therapy

Niels van de Roemer, TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg, Germany
The Pharmacodynamics of Actively Personalized RNA-Based Anti-Tumor Vaccination

Serena Zilio, University of Miami, USA
4PD Functionalized PAMAM Dendrimer Allows the in vivo Rehabilitation of Tumor Educated Myeloid Cells

16:30—17:00
Coffee Available

17:00—19:15
Chronic Inflammation and Cancer
Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting

* Wendy S. Garrett, Harvard School of Public Health, USA

Timothy C. Wang, Columbia University
GI Infection, Inflammation and Tumor Microenvironment

Fiona M. Powrie, University of Oxford, UK
Cellular and Molecular Pathways that Promote Inflammation-Driven Cancer

Nuray Gül, VU University Medical Center, Netherlands
Short Talk: Colon Resection-Induced Inflammation Stimulates Outgrowth of Liver Metastases from Circulating Tumor Cells

Curtis J. Henry, University of Colorado Anschutz Medical Campus, USA
Short Talk: Inflamm-Aging Reduces B-Progenitor Function Leading to Increased Selection for Oncogenically-Initiated B-Cells

Robert F. Schwabe, Columbia University, USA
Liver Cancer: Microbiome and Myofibroblasts Fuel the Flames


Following Session is for Immune Evolution in Cancer (X2)

17:00—19:15
Location, Location, Location: Stromal Cell Effects
Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting

* Alberto Mantovani, Istituto Clinico Humanitas/ Milan University, Italy

Ronen Alon, Weizmann Institute of Science, Israel
How Do Tumors Educate the Vasculature to Recruit Tumor Helper Cells?

Kornelia Polyak, Dana-Farber Cancer Institute, Harvard Medical School, USA
Leukocytes in Breast Tumor Progression

Sven Brandau, University Duisburg-Essen, Germany
Short Talk: Bi-Directional Interaction of Stromal Neutrophils and Tumor Cells Promotes Metastasis by Inducing an Invasive, NK-Resistant Tumor Cell Phenotype

Martina Seiffert, German Cancer Research Center, Germany
Short Talk: Chronic Lymphocytic Leukemia Patients Show Abnormalities within their Myeloid Cell Compartment

Shannon J. Turley, Genentech, USA
Influence of the Stromal Niche on Leukocyte Function in Solid Tumors

19:15—20:15
Social Hour with Lite Bites

19:30—22:00
Poster Session 1


TUESDAY, MARCH 11

07:00—08:00
Breakfast

08:00—11:15
Infection and Cancer Initiation
Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting

* Fiona M. Powrie, University of Oxford, UK

Martyn Plummer, International Agency for Research on Cancer, France
The Global Burden of Cancer Attributable to Infection

Cynthia L. Sears, Johns Hopkins University School of Medicine, USA
Colonic Commensals, B. fragilis and Colorectal Cancer (CRC)

Nicole Antonio, University of Bristol, UK
Short Talk: Live Imaging Studies of the Competing Inflammatory Responses to Tumors, Wounds and Infections in Adult and Larval Zebrafish

Johanna Classon, Karolinska Institutet, Sweden
Short Talk: Human Cytomegalovirus and Androgen Signaling in Prostate Cancer Progression

Xiao-Fan Wang, Duke University Medical Center, USA
Tumor Microenvironment: MicroRNAs and Metastasis

Elizabeth P. Murchison, University of Cambridge, UK
Clonally Transmissible Cancers in Dogs and Tasmanian Devils


Following Session is for Immune Evolution in Cancer (X2)

08:00—11:15
Co-Opting of Anti-Tumor Immunity by Myeloid-Derived Suppressor Cells
Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting

* Robert H. Vonderheide, University of Pennsylvania School of Medicine, USA

Olivera J. Finn, University of Pittsburgh School of Medicine, USA
MDSC in Premalignant Disease

Vincenzo Bronte, University of Verona, Italy
Tumor-Induced Immune Suppression by MDSC.

Kebin Liu, Georgia Regents University, USA
Short Talk: Deregulation of Apoptotic Factors Bcl-xL and Bax Confers Apoptotic Resistance to Myeloid-Derived Suppressive Cells and Contributes to Their Persistence in Cancers

Viktor Umansky, German Cancer Research Center, Germany
Short Talk: Neutralizing Immunosuppressive Melanoma Microenvironment

Suzanne Ostrand-Rosenberg, University of Maryland, USA
Inflammation and Alarmins as Drivers of Immune Suppressive Myeloid Cells and Tumor Progression

Dmitry I. Gabrilovich, Wistar Institute, USA
The Fate of Myeloid-Derived Suppressor Cells is Regulated Through TRAIL Receptors Mediated Apoptosis

09:20—09:40
Coffee Break

11:15—13:00
Poster Setup

13:00—22:00
Poster Viewing

11:15—17:00
On Own for Lunch and Recreation

16:30—17:00
Coffee Available

17:00—19:15
Re-Educating Tumor-Promoting Macrophages (Joint)
Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting

* Lisa M. Coussens, Oregon Health & Science University, USA

Jo A. Van Ginderachter, VIB-Vrije Universiteit Brussel, Belgium
Macrophage plasticity in the tumor microenvironment

Johanna A. Joyce, Memorial Sloan-Kettering Cancer Center, USA
Re-Educating Macrophages in the Tumor Microenvironment

Charlotte Rolny, Karolinska Institute, Sweden
Short Talk: SEMA3A Dictates a Pro-Inflammatory Program that Restricts Tumor Growth

David Liberg, Active Biotech AB, Sweden
Short Talk: Inhibition of S100A9/Receptor Interactions by Novel Small Molecules Reduces Tumor Growth and Promotes CD8+ T Cell Infiltration

Alberto Mantovani, Istituto Clinico Humanitas/ Milan University, Italy
Inflammation, Macrophage Polarization, and Cancer

19:15—20:15
Social Hour with Lite Bites

19:30—22:00
Poster Session 2


WEDNESDAY, MARCH 12

07:00—08:00
Breakfast

08:00—11:00
The Impact of the Microbiome on Cancer
Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting

* Cynthia L. Sears, Johns Hopkins University School of Medicine, USA

Wendy S. Garrett, Harvard School of Public Health, USA
Fusobacteria and Colon Cancer

Eric G. Pamer, Memorial Sloan-Kettering Cancer Center, USA
The Effects of Intestinal Tract Bacterial Diversity on Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation

Yiping W. Han, Case Western Reserve University, USA
Short Talk: A Novel Mechanism by which Oral Commensal Fusobacterium nucleatum Promotes Colorectal Cancer

Lei Chen, Hong Kong Baptist University, China
Short Talk: The Impacts of Herbal Triterpenoid Saponins on Gut Microbiota and Cancer in ApcMin/+ Mice

Johanna W. Lampe, Fred Hutchinson Cancer Research Center, USA
Effects of Diet and Modulation of Inflammation on Cancer Risk


Following Session is for Immune Evolution in Cancer (X2)

08:00—11:15
Evolving Immune Suppressive Mechanisms in the Tumor Microenvironment
Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting

* Vincenzo Bronte, University of Verona, Italy

Ruth Ganss, Harry Perkins Institute of Medical Research, Australia
Tumor-Targeted Therapy to Modulate Stroma

Andrea Schietinger, University of Washington, USA
Short Talk: Initial Tumor-Antigen Encounters in Pre-/Early Malignant Lesions Lead to CD8 T Cell Dysfunction

Jay A. Berzofsky, NCI, National Institutes of Health, USA
Short Talk: Blockade of TGF-beta to Overcome Negative Regulation in the Tumor Microenvironment: From Mice to Cancer Patients

Arthur Hurwitz, NCI, National Institutes of Health, USA
The Highs and Lows of T Cell Avidity: Tumor Immunity Meets Immune Suppression

Bill C. Dougall, Amgen, USA
Distinct Roles of RANKL in Cancer: RANKL-Dependent Osteoclasts in the Tumor/Bone Microenvironment and Direct effects of RANKL on Breast Tumor Initiation and Progression

09:20—09:40
Coffee Break

11:15—00:15
Meet the Editors Roundtable

* Teodoro Pulvirenti, Rockefeller University Press, USA

Christine Borowski, Nature Publishing Group, USA

Zoltan Fehervari, Nature Publishing Group, UK

Nancy R. Gough, AAAS/Science, USA

11:00—13:00
Poster Setup

13:00—22:00
Poster Viewing

11:15—14:30
On Own for Lunch and Recreation

14:30—16:30
Workshop 2: Insights into Immune Cell Function from Live Imaging (Joint)

* Mikael J. Pittet, Massachusetts General Hospital, USA

* Ronen Alon, Weizmann Institute of Science, Israel

Miranda L. Broz, University of California, San Francisco, USA
Distinct Lineages of Tolerogenic and Activating Myeloid Cells from Tumors

Esther N. Arwert, Albert Einstein College of Medicine, USA
Identification of Molecular and Functional Differences in Tumour Associated Macrophage Subsets

Liane Babes, University of Calgary, Canada
Visualizing Tumor Cell Killing by Immune Cells in the Liver

Guy Shakhar, Weizmann Institute of Science, Israel
Intravital Imaging of Melanoma Reveals that Target Cytolysis by CTLs Is Strictly Contact and Antigen-Dependent

Tali Feferman, Weizmann Institute of Science, Israel
Angiogenesis Promotes Intratumoral CTL Dissemination and Cytotoxicity

David Askew, Case Western Reserve University, USA
Heterogeneity of T Cell Acute Lymphoblastic Leukemia Cells Derived from Constitutive Expression of Intracellular Notch 1

Derek William Laux, Queen's Medical Research Institute, University of Edinburgh, UK
A Trophic Role for Innate Immunity in Cancer Progression

14:30—16:30
Workshop 3: Immune Suppressive Myeloid Cells (Joint)

* Lisa H. Butterfield, University of Pittsburgh, USA

* Rolf Kiessling, Karolinska Institute, Sweden

Yago Pico de Coaña, Karolinska Institutet, Sweden
Effects of Ipilimumab on Myeloid Derived Suppressor Cells in Advanced Melanoma Patients

Erik Thiele Orberg, Johns Hopkins School of Medicine, USA
Immature Myeloid Cells as a Link between Inflammation and Tumorigenesis in Bacterial Colitis-Associated Carcinogenesis

Xianming Huang, University of Texas Southwestern Medical Center Dallas, USA
Phosphatidylserine-Targeting Antibodies Induce M1 Macrophage Polarization, Promote Myeloid Derived Suppressor Cell Differentiation and Boost Tumor-Specific Immunity

Nelly Vey, Cancer Research Centre of Lyon, France
The Antimicrobial Peptide LL37 Activates Plasmacytoid Dendritic Cells in Breast Cancer

Rinat Zaynagetdinov, Vanderbilt University, USA
Alveolar Macrophages Promote Lung Tumorigenesis in the Context of Chronic Airway Inflammation through Differentiation of Regulatory T Cells (Tregs)

Seth B. Coffelt, Netherlands Cancer Institute, Netherlands
Gamma delta T Cells and Neutrophils Conspire together to Promote Breast Cancer Metastasis

Kellie A. Charles, University of Sydney, Australia
Monocytic Myeloid Derived Suppressor Cells (Mo-MDSC) Decrease with 5FU-based Chemotherapy in Colorectal Cancer Patients

Ofer Levy, Compugen Ltd., Israel
Identification of Novel Immune Checkpoints as Potential Targets for Cancer Immunotherapy

16:30—17:00
Coffee Available

17:00—19:15
Origins and Therapeutic Targeting of Myeloid Cells in Physiology and Cancer
Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting

* Eric G. Pamer, Memorial Sloan-Kettering Cancer Center, USA

Frederic Geissmann, King's College London, UK
In vivo Characterisation of the YS Progenitor for Tissue Resident Macrophages

Mikael J. Pittet, Massachusetts General Hospital, USA
Origins of Tumor-Associated Myeloid Cells

Alessia Zoso, University of Miami, USA
Short Talk: Molecular and Functional Characterization of IDO-Expressing Human Fibrocytic Myeloid Derived Suppressor Cells

Mary Christine Hollander, NCI/National Institutes of Health, USA
Short Talk: Myeloid Specific TGF-beta Signaling and Cancer Metastasis

Miriam Merad, Mount Sinai School of Medicine, USA
Tracing the Cell of Origin for Resident Macrophage Populations


Following Session is for Immune Evolution in Cancer (X2)

17:00—19:00
Antigen Presentation in the Tumor Microenvironment
Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting

* Olivera J. Finn, University of Pittsburgh School of Medicine, USA

Jose Conejo-Garcia, Wistar Institute, USA
Dynamic Expression of the Genomic Organizer SATB1 Regulates Dendritic Cell Differentiation and Immunostimulatory Functions in Cancer

Lisa H. Butterfield, University of Pittsburgh, USA
Short Talk: Tumor-Derived alpha-Fetoprotein Impairs the Differentiation and T Cell Stimulatory Activity of Human Dendritic Cells

Brad H. Nelson, BC Cancer Agency, Canada
Short Talk: Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer

Eduardo M. Sotomayor, Moffitt Cancer Center and Research Institute, USA
Epigenetic Manipulation of Antigen-Presenting Cells to Influence Immune Activation versus Immune Tolerance

19:15—20:15
Social Hour with Lite Bites

19:30—22:00
Poster Session 3


THURSDAY, MARCH 13

07:00—08:00
Breakfast

08:00—11:15
Inflammation as a Target and Modulator of Cancer Therapeutics
Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting

* Giorgio Trinchieri, NCI, National Institutes of Health, USA

Michael Karin, University of California, San Diego, USA
Liver Inflammation, Obesity and Cancer

Napoleone Ferrara, University of California, San Diego, USA
Myeloid Cells and VEGF?Independent Tumor Angiogenesis

Mauricio da Silva Caetano, University of Texas MD Anderson Cancer Center, USA
Short Talk: Pharmacologic Targeting of IL-6 Suppresses Tumor Progression in a K-ras Mutant Lung Cancer Mouse Model through Re-Educating the Tumor Microenvironment

Maryse Dagenais, McGill University, Canada
Short Talk: The Role of the Cellular Inhibitor of Apoptosis Protein cIAP2 in Colitis and Colitis-Associated Colorectal Cancer

Carola Ries, Roche Pharma Research and Early Devlopment, Germany
Targeting Tumor-Associated Macrophages in Cancer Patients

Martin Brown, Stanford University, USA
Myeloid Cells Govern the Response of Tumors to Irradiation


Following Session is for Immune Evolution in Cancer (X2)

08:00—11:00
Overcoming Immune Suppression in the Tumor Microenvironment
Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting

* Dmitry I. Gabrilovich, Wistar Institute, USA

Martin Oft, ARMO BioSciences, USA
All TILs, no TAMs - or how PEG-IL-10 Activates Intratumoral CD8 T Cell Cytotoxicity

George Coukos, University Hospital of Lausanne - CHUV, Switzerland
Immune Escape and Angiogenesis

Brian Ruffell, Oregon Health & Science University, USA
Short Talk: TH2 Cytokines Limit Chemotherapeutic Efficacy by Repressing Dendritic Cell Production of IL12

Sadna Budhu, Memorial Sloan-Kettering Cancer Center, USA
Short Talk: Blockade of Treg Derived TGF-beta Abrogates Suppression of Effector T Cell Function within the Tumor Microenvironment

Alan Serrels, University of Edinburgh, UK
Short Talk: Evading the Anti-Tumor Immune Response - A Novel Role for Focal Adhesion Kinase

Thomas Blankenstein, Max Delbruck Center for Molecular Medicine, Germany
Spontaneous and Therapy-Induced T Cell Responses to Cancer

09:20—09:40
Coffee Break

11:15—17:00
On Own for Lunch and Recreation

16:30—17:00
Coffee Available

17:00—19:15
Therapeutic Manipulation of the Tumor Microenvironment (Joint)
Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting

* Johanna A. Joyce, Memorial Sloan-Kettering Cancer Center, USA

* Suzanne Ostrand-Rosenberg, University of Maryland, USA

Robert H. Vonderheide, University of Pennsylvania School of Medicine, USA
Inflammatory Networks and Immune Privilege in Carcinoma

Giorgio Trinchieri, NCI, National Institutes of Health, USA
The Role of Inflammation in Carcinogenesis and Response to Cancer Therapy

Frances R. Balkwill, Barts Cancer Institute, Queen Mary University of London, UK
Targeting Inflammatory Cytokines and Chemokines

Carl H. June, University of Pennsylvania, USA
Adoptive Therapy with Engineered T Cells

19:15—20:15
Social Hour with Lite Bites

20:00—23:00
Entertainment


FRIDAY, MARCH 14

 
Departure


*Session Chair †Invited, not yet responded.



Keystone Symposia thanks our Sponsors for generously supporting this meeting:

BioLegend, Inc. Infinity Pharmaceuticals, Inc.
Roche
 

We gratefully acknowledge additional support for this conference from:

Cell Signaling Technology, Inc. Chroma Technology Corporation
MedImmune Myriad-RBM
Opsona Therapeutics Ltd
 

We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1R13CA183131-01

The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



Roche Diagnostics GmbH


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Amanda Deem, Assistant Director of Development, Email: AmandaD@keystonesymposia.org,
Phone:+1 970-262-2668

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676